On March 12, 2026, Leading Chinese Surgical Robotics Company Edge Medical  announced that its integrated multi-port, single-port and remote surgical robotic platform has been approved by China’s National Medical Products Administration (NMPA).

According to MedChina, this marks the first globally approved system that integrates multi-port, single-port, and remote surgical capabilities into a single unified platform under one regulatory approval.

This milestone is not merely about adding functionalities.

Multi-port, single-port, and remote surgery have traditionally evolved along independent technological pathways, each with distinct system architectures and operational logic. By integrating them into a unified control framework, the previously fixed relationships between procedure, device, and clinical scenario begin to loosen.

A single system can now support multiple surgical approaches.

This signals a broader shift: surgical robots are evolving from procedure-specific tools into cross-procedure, cross-scenario platforms.

The key question is:

How are these three technological pathways truly unified within one system?

Product Breakdown: How One System Enables Three Capabilities

1. Not a Combination, but a Unified Technical Foundation

The “three-in-one” concept could easily be misunderstood as a combination of separate systems. In reality, Edge Medical has achieved integration at the architectural level.

First, there is a unified technical foundation. Multi-port, single-port, and remote capabilities are designed to operate within the same system architecture from the outset, including shared control logic and data flow—rather than being integrated post hoc.

Second, the control system is unified. Both the multi-port and single-port robots are driven by the same control system, based on a consistent kinematic model, control algorithms, and feedback mechanisms.

Third, the surgeon interface is unified. The multi-port and single-port systems share the same surgeon console, eliminating the need to relearn operational logic across different platforms. This significantly lowers the learning curve.

Finally, remote capability is embedded at the system level. Local and remote procedures can be executed within the same framework, validating the completeness of the architecture.

Together, these elements define the true meaning of “three-in-one”:

three capabilities, inherently built into a single system from the ground up.

2. Capability Layering: What Each Modality Delivers

Within this unified architecture, multi-port, single-port, and remote capabilities function as complementary layers, rather than substitutes.

Multi-Port: The Execution Foundation for Complex Procedures

Multi-port robotic systems remain the backbone of complex minimally invasive surgery.

Within Edge’s platform, the MP2000 Multi-Port Surgical Robot serves as the execution foundation, offering:

• Stable robotic arm control for predictable motion

• Motion compensation to reduce tremor impact

• Multi-instrument coordination within a shared surgical field

• Adaptability in complex anatomical spaces

System-level optimizations include:

• Imaging: enhanced resolution, illumination, and color performance

• Control: refined hand guidance, tremor filtering, and instrument switching

• Transmission: low latency for real-time hand–eye coordination

• Instrumentation: coverage across multiple specialties and procedures

Within the integrated system, multi-port provides reliable execution in complex surgical scenarios.

Single-Port: Advancing Minimally Invasive Boundaries

Single-port surgery requires precise operation within highly constrained spaces, posing challenges in instrument design, kinematics, and collision management.

The SP1000 Plus Single-Port Surgical Robot introduces several key innovations:

• Dexterous arm technology enabling multi-quadrant operation without repositioning the patient

• Zero-pressure anchoring to minimize incision stress under extreme instrument angles

•  “Sleeve-contained deployment” allowing partial instrument deployment within the cannula, improving access to proximal lesions

• Expanded operational depth range for broader lesion coverage

Importantly, the single-port system shares the same control system and console as the multi-port system, enabling surgeons to transition without relearning.

As a result, single-port is moving from a high-barrier technique toward practical clinical adoption.

Remote Surgery: Extending Surgical Capability Across Distance

Remote surgery introduces challenges beyond robotics, including network latency, data fidelity, and system reliability.

Within Edge’s platform, remote capability is supported by:

• Low-latency communication for real-time control

• High-fidelity transmission for consistent feedback

• Robust safeguards against network instability

• Cloud connectivity for system coordination

In this architecture, a local console can directly control remote robotic arms, enabling seamless switching between on-site and remote procedures.

Remote capability thus enables the geographical extension of surgical expertise.

3. From Device to Platform: Enabling Full-Scenario Coverage

With full integration achieved, the system evolves from a set of functions into a platform covering diverse clinical scenarios.

It supports:

• Multiple specialties: urology, gynecology, general surgery, thoracic surgery

• Multiple approaches: flexible switching between multi-port and single-port

• Multiple modes: local surgery and remote collaboration

• Multiple applications: routine procedures and advanced clinical exploration

This positions the system as a true surgical platform:

Not a device for a single procedure, but a comprehensive carrier of surgical capability across scenarios.

Clinical and Market Implications:A System That Redefines Utilization

1. Clinical Perspective: From Device Adaptation to Pathway Selection

Historically, surgical approaches were tightly coupled with specific systems.

The integrated platform breaks this constraint.

Within one system:

• Surgeons can select multi-port for complex cases and single-port for minimally invasive needs

• Shared controls eliminate additional training burdens

• Remote capability is embedded directly into clinical workflows

The outcome is clear:

procedure selection becomes more patient-centric, and advanced techniques become more accessible.

2. Hospital Perspective: From Multiple Systems to One Platform

Traditionally, hospitals deploy separate systems for each capability.

The integrated platform consolidates them into one.

Key impacts include:

• Configuration: from multiple systems to a single platform

• Cost: centralized training and maintenance, improved utilization

• Capability building: multi-port ensures volume, single-port expands technique, remote enables external collaboration

Hospitals are no longer purchasing isolated devices, but deploying a comprehensive surgical capability system.

Back to Edge Medical: The Capability Structure Behind the Platform

The platform reflects Edge’s multi-year technological evolution:

• Multi-port systems established clinical foundations

• Single-port systems pushed technical boundaries

• Remote capabilities were validated through real-world deployment

These capabilities, developed over time, are now unified into a single system.

This integration is supported by:

• Unified control capability across modalities

• Integrated system architecture with remote built in from the outset

• Broad procedural adaptability across specialties

• Robust communication infrastructure

• Proven clinical collaboration across institutions

Only through the convergence of these capabilities can such a platform be realized.

Conclusion

The focus of the surgical robotics industry is shifting—from individual products and isolated innovations to system-level capability and clinical integration.

In this context, Edge Medical demonstrates a forward-looking approach.

As the first Chinese company and second globally to obtain regulatory approvals for multi-port, single-port, and natural orifice surgical robotic systems, it has built a comprehensive product portfolio.

With this approval, that portfolio evolves into a fully integrated system, transforming previously separate capabilities into a coherent whole.

As international expansion progresses, this platform is increasingly positioned for global scalability.

Edge’s leadership lies not only in its current products, but in the structure, integration, and execution of its overall strategy.

March 18, 2026, MedChina